188 related articles for article (PubMed ID: 11348531)
1. The story of CGP 40 215: studies on its efficacy and pharmacokinetics in African green monkey infected with Trypanosoma brucei rhodesiense.
Brun R; Burri C; Gichuki CW
Trop Med Int Health; 2001 May; 6(5):362-8. PubMed ID: 11348531
[TBL] [Abstract][Full Text] [Related]
2. In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.
Bacchi CJ; Brun R; Croft SL; Alicea K; Bühler Y
Antimicrob Agents Chemother; 1996 Jun; 40(6):1448-53. PubMed ID: 8726018
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
4. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
Heby O; Persson L; Rentala M
Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
[TBL] [Abstract][Full Text] [Related]
5. Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.
Barker RH; Liu H; Hirth B; Celatka CA; Fitzpatrick R; Xiang Y; Willert EK; Phillips MA; Kaiser M; Bacchi CJ; Rodriguez A; Yarlett N; Klinger JD; Sybertz E
Antimicrob Agents Chemother; 2009 May; 53(5):2052-8. PubMed ID: 19289530
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)- furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration.
Mdachi RE; Thuita JK; Kagira JM; Ngotho JM; Murilla GA; Ndung'u JM; Tidwell RR; Hall JE; Brun R
Antimicrob Agents Chemother; 2009 Mar; 53(3):953-7. PubMed ID: 19064893
[TBL] [Abstract][Full Text] [Related]
7. Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor.
Bacchi CJ; Nathan HC; Yarlett N; Goldberg B; McCann PP; Bitonti AJ; Sjoerdsma A
Antimicrob Agents Chemother; 1992 Dec; 36(12):2736-40. PubMed ID: 1482141
[TBL] [Abstract][Full Text] [Related]
8. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
[TBL] [Abstract][Full Text] [Related]
9. The phenomenon of treatment failures in Human African Trypanosomiasis.
Brun R; Schumacher R; Schmid C; Kunz C; Burri C
Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
[TBL] [Abstract][Full Text] [Related]
10. Trypanocidal activity of 8-methyl-5'-{[(Z)-4-aminobut-2-enyl]-(methylamino)}adenosine (Genz-644131), an adenosylmethionine decarboxylase inhibitor.
Bacchi CJ; Barker RH; Rodriguez A; Hirth B; Rattendi D; Yarlett N; Hendrick CL; Sybertz E
Antimicrob Agents Chemother; 2009 Aug; 53(8):3269-72. PubMed ID: 19451291
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma brucei rhodesiense: use of an antigen detection enzyme immunoassay for evaluation of response to chemotherapy in infected vervet monkeys (Cercopithecus aethiops).
Gichuki CW; Nantulya VM; Sayer PD
Trop Med Parasitol; 1994 Sep; 45(3):237-42. PubMed ID: 7899795
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis.
Wring S; Gaukel E; Nare B; Jacobs R; Beaudet B; Bowling T; Mercer L; Bacchi C; Yarlett N; Randolph R; Parham R; Rewerts C; Platner J; Don R
Parasitology; 2014 Jan; 141(1):104-18. PubMed ID: 24007596
[TBL] [Abstract][Full Text] [Related]
13. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
[TBL] [Abstract][Full Text] [Related]
15. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.
Kaiser M; Bray MA; Cal M; Bourdin Trunz B; Torreele E; Brun R
Antimicrob Agents Chemother; 2011 Dec; 55(12):5602-8. PubMed ID: 21911566
[TBL] [Abstract][Full Text] [Related]
16. Response of a T. b. rhodesiense stock with reduced drug susceptibility in vitro to treatment in mice and cattle.
Enyaru JC; Matovu E; Lubega GW; Kaminsky R
Acta Trop; 1998 Jun; 69(3):261-9. PubMed ID: 9638278
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of human African trypanosomiasis.
Burchmore RJ; Ogbunude PO; Enanga B; Barrett MP
Curr Pharm Des; 2002; 8(4):256-67. PubMed ID: 11860365
[TBL] [Abstract][Full Text] [Related]
18. In vivo efficacies of 5'-methylthioadenosine analogs as trypanocides.
Bacchi CJ; Sanabria K; Spiess AJ; Vargas M; Marasco CJ; Jimenez LM; Goldberg B; Sufrin JR
Antimicrob Agents Chemother; 1997 Oct; 41(10):2108-12. PubMed ID: 9333033
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new S-adenosylmethionine decarboxylase inhibitors for the treatment of Human African Trypanosomiasis (HAT).
Hirth B; Barker RH; Celatka CA; Klinger JD; Liu H; Nare B; Nijjar A; Phillips MA; Sybertz E; Willert EK; Xiang Y
Bioorg Med Chem Lett; 2009 Jun; 19(11):2916-9. PubMed ID: 19419862
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of second stage human African trypanosomiasis: comparison between the parenteral diamidine DB829 and its oral prodrug DB868 in vervet monkeys.
Thuita JK; Wolf KK; Murilla GA; Bridges AS; Boykin DW; Mutuku JN; Liu Q; Jones SK; Gem CO; Ching S; Tidwell RR; Wang MZ; Paine MF; Brun R
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003409. PubMed ID: 25654243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
